Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-03-15
著者
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
永井 正
自治医科大学内科学講座血液学部門
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
永井 正
自治医科大学 内科学講座血液学部門
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Okada Masaya
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Okada Masaya
兵庫医科大学 総合内科
-
Okada Masaya
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Naoe Tomoki
大垣市民病院 血液内科
-
Nagai Tadashi
東京慈恵会医科大学 内科学講座血液内科
-
Nagai Tadashi
Division Of Hematology Department Of Medicine Jichi Medical University
-
Nagai Tadashi
Division Of Hematology Jichi Medical University
-
Miyawaki Shuichi
琉球大学 医学部血液免疫検査学分野
-
Miyawaki S
Division Of Hematology Tokyo Metropolitan Ohtsuka Hospital
-
Miyawaki Shuichi
Division Of Hematology Saiseikai Maebashi Hospital
-
Miyawaki Shuichi
Leukemia Research Center Saiseikai Maebashi Hospital
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Ohtake S
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Tanimoto Mitsune
国立がんセンター中央病院 造血幹細胞移植グループ
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
Okumura Hirokazu
Cellular Transplantation Biology Kanazawa University Graduate School Of Medical Science
-
Okumura Hirokazu
日本医科大学 第三内科
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
KIYOI Hitoshi
Nagoya University Hospital
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Kageyama Shinichi
浜松医科大学 第3内科
-
Kageyama Shinichi
Department Of Hematology And Oncology Mie University Graduate School Of Medicine
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Kiyoi Hitoshi
豊橋市民病院 血液･腫瘍内科
-
Kosugi H
Department Of Hematology Ogaki Municipal Hospital
-
Kiyoi Hitoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Asou Norio
愛知県がんセンター
-
Asou N
Department Of Hematology Kumamoto University School Of Medicine
-
Asou Norio
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Asou Norio
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Murata Takashi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Ohtake Shigeki
Department Of Clinical Laboratory Sciences Graduate School Of Medical Sciences Kanazawa University
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Kamiya Yoshikazu
愛知がんセンター 血液･細胞療法部
-
Tomonaga Masao
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Tanaka J
Stem Cell Transplantation Center Hokkaido University Hospital
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Naoe T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Okayama Kenichi
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Odagiri Keiichi
浜松医科大学 救急医学
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Okada Masaya
Hyogo Coll. Medicine Nishinomiya Jpn
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Sato M
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Asou Norio
Department Of Hematology Kumamoto University School Of Medicine
-
Handa Hiroshi
Department Of Medicine And Clinical Science Gunma University Graduate School Of Medicine
-
Minami S
Nagasaki Cml Study Group
-
Minami S
(tottori University) United Graduate School Yamaguchi University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University School Of Medicine
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
MITSUI Yoko
Department of Surgery
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University Hospital
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Taniwaki Masafumi
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
岡田 昌也
兵庫医科大学病院血液内科
-
Kosugi Hiroshi
Institute For Chemical Research Tohoku University
-
Kodera Y
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Shirai Masato
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Miyazaki Yasushi
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University
-
Miyazaki Yoshitsugu
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Maeda Yasuhiro
Department Of Hematology Kinki University School Of Medicine
-
Taniwaki Masafumi
Department Of Clinical Molecular Genetics And Laboratory Medicine Kyoto Prefectural University Of Me
-
Taniwaki Masafumi
The Third Department Of Internal Medicine Kyoto Prefectural Medical School
-
Okumura Hirokazu
Kanazawa Univ. Graduate School Of Medical Sci. Kanazawa Jpn
-
Okumura Hirokazu
Department Of Cellular Transplantation Biology Kanazawa University Graduate School Of Medical Scienc
-
Okumura Hirokazu
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Takeuchi Jin
Department Of Internal Medicine Nihon University School Of Medicine
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Oncology Center Hamamatsu University School Of Medicine
-
Tadashi Nagai
Division Of Hematology Department Of Medicine Jichi Medical University
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Taguchi Jun
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taguchi Jun
Department Of Hematology Kanagawa Cancer Center
-
Komiyam Y
Akita Univ. School Of Medicine Akita Jpn
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Katayama Yoshio
Second Department Of Internal Medicine Okayama University Medical School
-
Tamura Jun'ichi
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Yano Kunio
県西部浜松医療センター
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Ohnishi Kazunori
The Division Of Hematology Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Handa Hiroshi
Department Of Bioscience And Biotechnology Tokyo Institute Of Technology
-
Asano Naoko
Department Of Laboratory Medicine Shinshu University Hospital
-
Asano Naoko
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Of Medical Science
-
Maeda Yasuhiro
Department Of Applied Physics Tokyo Institute Of Technology
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Kanazawa University
-
Takeuchi Jin
Department Of Hematology And Rheumatology Division Of Medicine Nihon University School Of Medicine
-
Yagasaki Fumiharu
Department Of Public Health Shimane University Faculty Of Medicine
-
Ohmachi Ken
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Mori Sayaka
Department Of Clinical Laboratory Nagasaki University Hospital
-
Fujita Yasuyuki
Department Of Public Health Shimane University Faculty Of Medicine
-
MAEDA Yasuhiro
Department of Agricultural Chemistry, College of Agriculture, University of Osaka Prefecture
-
Nagai Tadashi
Division of Cell Therapy, Jichi Medical University Hospital, Shimotsuke
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Increased macrophage colony-stimulating factor levels in patients with Graves' disease
- Increased macrophage colony-stimulating factor levels in patients with Graves' disease
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?
- Refractory Crow-Fukase Syndrome (POEMS Syndrome) Successfully Treated with High-Dose Melphalan followed by Autologous Peripheral Blood Stem Cell Transplantation
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- X-Linked Lymphoproliferative Disease in an Adult
- Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Alcoholic Ketoacidosis Associated with Multiple Complications : Report of 3 Cases
- How High Can We Increase Complete Remission Rate in Adult Acute Myeloid Leukemia?
- 4 Activity of the Science Council of Japan Aiming for Tobacco-free Society in Japan(The 6th Anti-Smoking Promotion Seminar, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Treatment of chronic myeloid leukemia with imatinib mesylate
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue